Novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-p yridin4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl} - (2-chlorophenyl)-methanone

Details for Australian Patent Application No. 2007337255 (hide)

Owner Eli Lilly and Company

Inventors Chen, Pingyun; Kopach, Michael E.; Kobierski, Michael Edward

Agent Spruson & Ferguson

Pub. Number AU-A-2007337255

PCT Pub. Number WO2008/079600

Priority 60/870,851 20.12.06 US

Filing date 4 December 2007

Wipo publication date 3 July 2008

International Classifications

C07D 213/53 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

11 June 2009 PCT application entered the National Phase

  PCT publication WO2008/079600 Priority application(s): WO2008/079600

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007337263-Compositions and methods for the expression of nucleic acids

2007337236-Automated tank cleaning and monitoring device